Literature DB >> 16409474

CHO cells expressing the high affinity alpha(IIb)beta3 T562N integrin demonstrate enhanced adhesion under shear.

P Legendre1, A Salsmann, J Rayes, O Trassard, N Kieffer, D Baruch.   

Abstract

BACKGROUND: Alpha(IIb)beta3-mediated platelet adhesive interactions in the vasculature, which are dependent on the functional state of this receptor, may be sensitive to shear forces.
OBJECTIVES: To evaluate the influence of the alpha(IIb)beta3 affinity state on cell attachment under flow, we compared Chinese hamster ovary cells expressing the low affinity alpha(IIb)beta3 wild-type (wt) receptor to those expressing the high affinity alpha(IIb)beta3 T562N receptor.
MATERIALS AND METHODS: We designed a real-time videomicroscopy adhesion assay for von Willebrand factor (VWF) or fibrinogen under flow conditions.
RESULTS: At 50 s(-1), alpha(IIb)beta3 T562N supported higher cell adhesion to fibrinogen (63.3 +/- 2.9 cells/field) than alpha(IIb)beta3 wt (38.7 +/- 2.4 cells/field, P < 0.0001). At 100 s(-1), alpha(IIb)beta3 T562N mediated cell adhesion (40.5 +/- 3.8 cells/field), while alpha(IIb)beta3 wt did not (5.3 +/- 1.4 cells/field, P < 0.001), allowing to discriminate the efficiency of each receptor. Similar findings were observed for adhesion to VWF. Complete inhibition of cell adhesion to fibrinogen was achieved with 800 microM fibrinogen gamma-chain dodecapeptide [HHLGGAKQAGDV (H12)], while Arg-Gly-Asp-Ser (RGDS) peptide (10-1000 microM) induced a dose-dependent cell detachment. These results suggest that the H12 motif allows initial attachment, in contrast to the RGDS site, which strengthens the stability of adhesion. Interestingly, compared with wt, a 10-fold lower concentration of RGDS was required to reach a similar reduction of cell adhesion mediated by alpha(IIb)beta3 T562N.
CONCLUSIONS: Our data show that alpha(IIb)beta3 activation is associated with a stabilization of integrin binding to fibrinogen or VWF under shear.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16409474     DOI: 10.1111/j.1538-7836.2005.01653.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  5 in total

1.  The cleavage of neutrophil leukosialin (CD43) by cathepsin G releases its extracellular domain and triggers its intramembrane proteolysis by presenilin/gamma-secretase.

Authors:  Agnès Mambole; Dominique Baruch; Patrick Nusbaum; Sylvain Bigot; Misa Suzuki; Philippe Lesavre; Minoru Fukuda; Lise Halbwachs-Mecarelli
Journal:  J Biol Chem       Date:  2008-06-27       Impact factor: 5.157

2.  Human endoglin as a potential new partner involved in platelet-endothelium interactions.

Authors:  Elisa Rossi; Miguel Pericacho; Christilla Bachelot-Loza; Dominique Pidard; Pascale Gaussem; Sonia Poirault-Chassac; Francisco J Blanco; Carmen Langa; Consuelo González-Manchón; Jose M Lopez Novoa; David M Smadja; Carmelo Bernabeu
Journal:  Cell Mol Life Sci       Date:  2017-10-28       Impact factor: 9.261

3.  The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction.

Authors:  Reinhard Schneppenheim; Natalie Hellermann; Maria A Brehm; Ulrike Klemm; Tobias Obser; Volker Huck; Stefan W Schneider; Cécile V Denis; Alexander Tischer; Matthew Auton; Winfried März; Emma-Ruoqi Xu; Matthias Wilmanns; Rainer B Zotz
Journal:  Blood       Date:  2018-10-26       Impact factor: 25.476

4.  Inhibition of αIIbβ3 Ligand Binding by an αIIb Peptide that Clasps the Hybrid Domain to the βI Domain of β3.

Authors:  Wen Hwa Lee; Elisabeth Schaffner-Reckinger; Demokritos C Tsoukatos; Kelly Aylward; Vassilios Moussis; Vassilios Tsikaris; Paraskevi Trypou; Marion Egot; Dominique Baruch; Nelly Kieffer; Christilla Bachelot-Loza
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

5.  Gain-of-Function Variant p.Pro2555Arg of von Willebrand Factor Increases Aggregate Size through Altering Stem Dynamics.

Authors:  Volker Huck; Po-Chia Chen; Emma-Ruoqi Xu; Alexander Tischer; Ulrike Klemm; Camilo Aponte-Santamaría; Christian Mess; Tobias Obser; Fabian Kutzki; Gesa König; Cécile V Denis; Frauke Gräter; Matthias Wilmanns; Matthew Auton; Stefan W Schneider; Reinhard Schneppenheim; Janosch Hennig; Maria A Brehm
Journal:  Thromb Haemost       Date:  2021-04-14       Impact factor: 6.681

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.